Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer-Reference-Cited by-同舟云学术

Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer

Published:2007-05-22 Issue:12 Volume:17 Page:3139-3147
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Freudenberg Lutz S.,Frilling Andrea,Kühl Hilmar,Müller Stefan P.,Jentzen Walter,Bockisch Andreas,Antoch Gerald

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-007-0682-2.pdf

Reference37 articles.

1. Gilliland FD, Hunt WC, Morris DM et al (1997) Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer 79:564–573

2. Schlumberger MJ (1999) Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status. J Endocrinol Invest 22(11 Suppl):3–7

3. Maxon HR (1999) Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer. Q J Nucl Med 43:313–323

4. Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338:297–306

5. Frilling A, Gorges R, Tecklenborg K et al (2000) Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 128:1067–1074

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent Thyroid Carcinoma in a Dog - Diagnosis by 18F-Fluorodeoxyglucose Positron Emission Tomography;ACTA SCI VET;2023

2. Role of 18F-FDG PET/CT in detection of hematogenous metastases of advanced differentiated thyroid carcinoma: a systematic review and meta-analysis;Journal of Cancer Metastasis and Treatment;2021

3. Verfahrensanweisung für die Iod-131 Ganzkörperszintigrafie beim differenzierten Schilddrüsenkarzinom (Version 5);Nuklearmedizin;2019-04-29

4. Iod-131-Ganzkörperszintigraphie beim differenzierten Schilddrüsenkarzinom;Nuklearmedizin;2018-08

5. Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer;PLOS ONE;2016-09-06